D. A. Whitaker

Attenuation of platelet reactivity by enoxaparin compared with unfractionated heparin in patients undergoing haemodialysis.

B. Sobel, D. Schneider, R. Solomon, 2004, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

The effects of bivalirudin compared with those of unfractionated heparin plus eptifibatide on inflammation and thrombin generation and activity during coronary intervention

H. Dauerman, B. Sobel, D. Schneider, 2005, Coronary artery disease.

Efficiency in clinical research: assessment in vitro of potential anti-thrombotic drug interactions

B. Sobel, D. Schneider, D. A. Whitaker, 2004, Coronary artery disease.

Increased ability of tirofiban to maintain its inhibitory effects on the binding of fibrinogen to platelets in blood from patients with and without diabetes mellitus

B. Sobel, D. Schneider, F. Keating, 2006, Coronary artery disease.

Variation in the Ability of Glycoprotein IIb-IIIa Antagonists to Exert and Maintain Their Inhibitory Effects on the Binding of Fibrinogen

B. Sobel, D. Schneider, P. Q. Baumann, 2005, Journal of cardiovascular pharmacology.

Increased expression of platelet P-selectin and formation of platelet-leukocyte aggregates in blood from patients treated with unfractionated heparin plus eptifibatide compared with bivalirudin.

H. Dauerman, B. Sobel, D. Schneider, 2006, Thrombosis research.

Augmentation of inhibitory effects of glycoprotein IIb-IIIa antagonists in patients with diabetes.

B. Sobel, D. Schneider, F. Keating, 2004, Thrombosis research.

Relation of augmented platelet reactivity to the magnitude of distribution of atherosclerosis.

B. Sobel, D. Schneider, M. Ricci, 2004, The American journal of cardiology.